StockData

FMC vs Innospec

FMC and IOSP side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How FMC and IOSP compare

Innospec is the larger company, worth 2.2 times as much as FMC ($1.9B against $877M).

Innospec grew revenue faster over the last twelve months (4.7% versus −22.0% for FMC).

Both pay dividends: FMC yields 5.7% and Innospec 2.3%.

Innospec scores higher on the StockData Score (14 against 6 for FMC), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricFMCIOSP
Size and price
Market cap$877M$1.9B
Share price$5.64$78.29
Change, 1 year−59.7%4.3%
Change, 5 years−94.6%−10.4%
Beta (5Y)0.800.86
Employees5,5002,450
StockData Score
Total score614 (better)
Valuation score14 (better)
Growth score01 (better)
Performance score01 (better)
Health score16 (better)
Dividend score4 (better)2
Valuation
P/S0.3× (better)1.0×
P/B–1.4×
EV/EBITDA–8.3×
P/FCF2.4×–
FCF yield42.2%–
Fair value–$110.48
Margin of safety–29.1%
Growth
Revenue growth (TTM)−22.0%4.7% (better)
Revenue growth, 5Y average−5.7%8.3% (better)
EPS growth, 5Y average–32.1%
Profitability
Gross margin22.0%27.7% (better)
Operating margin−97.0%8.8% (better)
Net margin−151%–
FCF margin13.1%–
Return on equity−227%–
Return on invested capital−38.4%12.4% (better)
Financial health
Debt / equity–0.00
Interest coverage−10.0×–
Current ratio1.662.95 (better)
Altman Z-score−0.195.05 (better)
Piotroski F-score2–
Dividends and buybacks
Dividend yield5.7% (better)2.3%
Years of dividend growth012 (better)
Dividend growth, 5Y average0.22%10.5% (better)
Buyback yield−46.0%0.70% (better)
Shareholder yield−40.3%3.0% (better)
Ownership
Held by institutions82.3%101%
Held by insiders20.9%1.6%
Insider net buying, 12 months$202K (better)−$902K
Superinvestors holding1–
Short interest, % of float31.2%1.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.